Biosimilar Market: Information By Product (Recombinant Peptides), Disease (Oncology, Chronic Diseases, Blood Disorders), and Manufacturing (In-House Manufacturing)—Forecast Till 2027

Feb 21, 2020   Global Statistics Representing Biosimilar Market Scenario Biosimilar is a biologic medical product, which is similar to the originator biologic products. As per the European Medicines Agency (EMA), a biosimilar is biomedicine that has the same characteristics as the biomedicines licensed in the European Union (EU). For the record, early biologics, erythropoietin (EPO), insulin, and growth hormones have been invaluable for the treatment and medication of major illnesses, such as anemia, renal di...
LIST OF TABLES & FIGURES

Tables and figures

LIST OF TABLES

TABLE 1       Global Biosimilars Market Share, By Product, 2017–2027 (USD Million)

TABLE 2       Recombinant Peptides Nutrition Market Share, By Region, 2017–2027 (USD Million)

TABLE 3       Recombinant Non-Glycosylated Proteins Market Share, By Region, 2017–2027 (USD Million)

TABLE 4       Global Biosimilars Market Share, By Manufacturing, 2017–2027 (USD Million)

TABLE 5       Contract Manufacturing Market Share, By Region, 2017–2027 (USD Million)

TABLE 6       In-House Manufacturing Market Share, By Region, 2017–2027 (USD Million)

TABLE 7       Research Laboratories Market Share, By Region, 2016–2026, (USD Million)

TABLE 8       Global Biosimilars Market Share Value, 2017–2027 (USD Million)

TABLE 9       America Biosimilars Market Share Value, By Region, 2017–2027 (USD Million)

TABLE 10     America Biosimilars Market Share value, By Product, 2017–2027 (USD Million)

TABLE 11     America Biosimilars Market Share value, By Manufacturing, 2017–2027 (USD Million)

TABLE 12     North America Biosimilars Market Share Value, By Country, 2017–2027 (USD Million)

TABLE 13     North America Biosimilars Market Share value, By Product, 2017–2027 (USD Million)

TABLE 14     North America Biosimilars Market Share value, By Manufacturing, 2017–2027 (USD Million)

TABLE 15     U.S. Biosimilars Market share, By Product, 2017–2027 (USD Million)

TABLE 16     U.S. Biosimilars Market share, By Manufacturing, 2017–2027 (USD Million)

TABLE 17     Canada Biosimilars Market share, By Product, 2017–2027 (USD Million)

TABLE 18     Canada Biosimilars Market share, By Manufacturing, 2017–2027 (USD Million)

TABLE 19     Mexico Biosimilars Market share, By Product, 2017–2027 (USD Million)

TABLE 20     Mexico Biosimilars Market share, By Manufacturing, 2017–2027 (USD Million)

TABLE 21     Latin America Biosimilars Market share, By Country, 2017–2027 (USD Million)

TABLE 22     Latin America Biosimilars Market share, By Product, 2017–2027 (USD Million)

TABLE 23     Latin America Biosimilars Market share, By Manufacturing, 2017–2027 (USD Million)

TABLE 24     Brazil Biosimilars Market share, By Product, 2017–2027 (USD Million)

TABLE 25     Brazil Biosimilars Market share, By Manufacturing, 2017–2027 (USD Million)

TABLE 26     Argentina Biosimilars Market share, By Product, 2017–2027 (USD Million)

TABLE 27     Argentina Biosimilars Market share, By Manufacturing, 2017–2027 (USD Million)

TABLE 28     Rest of Latin America Biosimilars Market share, By Product, 2017–2027 (USD Million)

TABLE 29     Rest of Latin America Biosimilars Market share, By Manufacturing, 2017–2027 (USD Million)

TABLE 30     Europe Biosimilars Market Share Value, By Region, 2017–2027 (USD Million)

TABLE 31     Europe Biosimilars Market share, By Product, 2017–2027 (USD Million)

TABLE 32     Europe Biosimilars Market share, By Manufacturing, 2017–2027 (USD Million)

TABLE 33     Western Europe Biosimilars Market share, By Country, 2017–2027 (USD Million)

TABLE 34     Western Europe Biosimilars Market share, By Product, 2017–2027 (USD Million)

TABLE 35     Western Europe Biosimilars Market share, By Manufacturing, 2017–2027 (USD Million)

TABLE 36     Germany Biosimilars Market share, By Product, 2017–2027 (USD Million)

TABLE 37     Germany Biosimilars Market share, By Manufacturing, 2017–2027 (USD Million)

TABLE 38     France Biosimilars Market share, By Product, 2017–2027 (USD Million)

TABLE 39     France Biosimilars Market share, By Manufacturing, 2017–2027 (USD Million)

TABLE 40     U.K Biosimilars Market share, By Product, 2017–2027 (USD Million)

TABLE 41     U.K Biosimilars Market share, By Manufacturing, 2017–2027 (USD Million)

TABLE 42     Italy Biosimilars Market share, By Product, 2017–2027 (USD Million)

TABLE 43     Italy Biosimilars Market share, By Manufacturing, 2017–2027 (USD Million)

TABLE 44     Spain Biosimilars Market share, By Product, 2017–2027 (USD Million)

TABLE 45     Spain Biosimilars Market share, By Manufacturing, 2017–2027 (USD Million)

TABLE 46     Rest of Western Europe Biosimilars Market share, By Product, 2017–2027 (USD Million)

TABLE 47     Rest of Western Europe Biosimilars Market share, By Manufacturing, 2017–2027 (USD Million)

TABLE 48     Eastern Europe Biosimilars Market share, By Product, 2017–2027 (USD Million)

TABLE 49     Eastern Europe Biosimilars Market share, By Manufacturing, 2017–2027 (USD Million)

TABLE 50     Asia-Pacific Biosimilars Market Share Value, By Country, 2017–2027 (USD Million)

TABLE 51     Asia-Pacific Biosimilars Market share, By Product, 2017–2027 (USD Million)

TABLE 52     Asia-Pacific Biosimilars Market share, By Manufacturing, 2017–2027 (USD Million)

TABLE 53     Japan Biosimilars Market share, By Product, 2017–2027 (USD Million)

TABLE 54     Japan Biosimilars Market share, By Manufacturing, 2017–2027 (USD Million)

TABLE 55     China Biosimilars Market share, By Product, 2017–2027 (USD Million)

TABLE 56     China Biosimilars Market share, By Manufacturing, 2017–2027 (USD Million)

TABLE 57     Australia Biosimilars Market share, By Product, 2017–2027 (USD Million)

TABLE 58     Australia Biosimilars Market share, By Manufacturing, 2017–2027 (USD Million)

TABLE 59     India Biosimilars Market share, By Product, 2017–2027 (USD Million)

TABLE 60     India Biosimilars Market share, By Manufacturing, 2017–2027 (USD Million)

TABLE 61     South Korea Biosimilars Market share, By Product, 2017–2027 (USD Million)

TABLE 62     South Korea Biosimilars Market share, By Manufacturing, 2017–2027 (USD Million)

TABLE 63     Rest of Asia-pacific Biosimilars Market share, By Product, 2017–2027 (USD Million)

TABLE 64     Rest of Asia-pacific Biosimilars Market share, By Distribution Channel, 2017–2027 (USD Million)

TABLE 65     Middle East and Africa Biosimilars Market Share Value, By Region, 2017–2027 (USD Million)

TABLE 66     Middle East and Africa Biosimilars Market share, By Product, 2017–2027 (USD Million)

TABLE 67     Middle East and Africa Biosimilars Market share, By Manufacturing, 2017–2027 (USD Million)

TABLE 68     Middle East Biosimilars Market share, By Country, 2017–2027 (USD Million)

TABLE 69     Middle East Biosimilars Market share, By Product, 2017–2027 (USD Million)

TABLE 70     Middle East Biosimilars Market share, By Manufacturing, 2017–2027 (USD Million)

TABLE 71     Saudi Arabia Biosimilars Market share, By Product, 2017–2027 (USD Million)

TABLE 72     Saudi Arabia Biosimilars Market share, By Manufacturing, 2017–2027 (USD Million)

TABLE 73     UAE Biosimilars Market share, By Product, 2017–2027 (USD Million)

TABLE 74     UAE Biosimilars Market share, By Manufacturing, 2017–2027 (USD Million)

TABLE 75     Qatar Biosimilars Market share, By Product, 2017–2027 (USD Million)

TABLE 76     Qatar Biosimilars Market share, By Manufacturing, 2017–2027 (USD Million)

TABLE 77     Rest of Middle East Biosimilars Market share, By Product, 2017–2027 (USD Million)

TABLE 78     Rest of Middle East Biosimilars Market share, By Manufacturing, 2017–2027 (USD Million)

TABLE 79     Africa Biosimilars Market share, By Product, 2017–2027 (USD Million)

TABLE 80     Africa Biosimilars Market share, By Manufacturing, 2017–2027 (USD Million)

LIST OF FIGURES

FIGURE 1     Global Biosimilars Market Overview

FIGURE 2     Value Chain Analysis

FIGURE 3     Bargaining Power of Suppliers

FIGURE 4     Bargaining Power of Buyers

FIGURE 5     Threat of Substitutes

FIGURE 6     Threat of New Entrants

FIGURE 7     Competitive Rivalry

FIGURE 8     Biosimilars Market, Market Share Analysis, 2018

FIGURE 9     Global Biosimilars Market, 2017-2027

FIGURE 10  U.S. Biosimilars Market Share, 2017–2027 (USD Million)

FIGURE 11  Canada Biosimilars Market Share, 2017–2027 (USD Million)

FIGURE 12  Mexico Biosimilars Market Share, 2017–2027 (USD Million)

FIGURE 13  Western Europe Biosimilars Market Share, 2017–2027 (USD Million)

FIGURE 14  Germany Biosimilars Market Share, 2017–2027 (USD Million)

FIGURE 15  France Biosimilars Market Share, 2017–2027 (USD Million)

FIGURE 16  U.K Biosimilars Market Share, 2017–2027 (USD Million)

FIGURE 17  Italy Biosimilars Market Share, 2017–2027 (USD Million)

FIGURE 18  Spain Biosimilars Market Share, 2017–2027 (USD Million)

FIGURE 19  Rest of Western Europe Biosimilars Market Share, 2017–2027 (USD Million)

FIGURE 20  Eastern Europe Biosimilars Market Share, 2017–2027 (USD Million)

FIGURE 21  Japan Biosimilars Market Share, 2017–2027 (USD Million)

FIGURE 22  China Biosimilars Market Share, 2017–2027 (USD Million)

FIGURE 23  Australia Biosimilars Market Share, 2017–2027 (USD Million)

FIGURE 24  India Biosimilars Market Share, 2017–2027 (USD Million)

FIGURE 25  South Korea Biosimilars Market Share, 2017–2027 (USD Million)

FIGURE 26  Rest of Asia-pacific Biosimilars Market Share, 2017–2027 (USD Million)

FIGURE 27  Middle East Biosimilars Market Share, 2017–2027 (USD Million)

FIGURE 28  Saudi Arabia Biosimilars Market Share, 2017–2027 (USD Million)

FIGURE 29  UAE Biosimilars Market Share, 2017–2027 (USD Million)

FIGURE 30  Qatar Biosimilars Market Share, 2017–2027 (USD Million)

FIGURE 31  Rest of Middle East Biosimilars Market Share, 2017–2027 (USD Million)

FIGURE 32  Africa Biosimilars Market Share, 2017–2027 (USD Million)

FIGURE 33  Biocon: Revenue Analysis, (USD Million)

FIGURE 34  Biocon: Segment Revenue 2017 (%)